Table 6

Clinical pathology in both treatment groups

Dimeticone group

n (%)

Permethrin group

n (%)

P value

Cervical lymphadenopathy:

Before treatment

49/73 (67.1%)

54/72 (75.0%)

P = 0.3

Day 2

51/73 (69.9%)

52/72 (72.2%)

P = 0.8

Day 4

52/73 (71.2%)

49/72 (68.1%)

P = 0.7

Day 7

39/73 (53.4%)

46/72 (63.9%)

P = 0.2

Day 9

41/72 (56.9%)

45/71 (63.4%)

P = 0.7

Bacterial superinfection of lesions:

Before treatment

1/73 (1.4%)

0/72 (0%)

P = 0.3

Day 2

1/73 (1.4%)

1/72 (1.4%)

P = 1.0

Day 4

1/73 (1.4%)

0/72 (0%)

P = 0.3

Day 7

0/73 (0%)

0/72 (0%)

P = 1.0

Day 9

0/72 (0%)

0/71 (0%)

P = 1.0

Heukelbach et al. BMC Infectious Diseases 2008 8:115   doi:10.1186/1471-2334-8-115